More stories
Is Cannabis Psychedelic? Examining the Scientific Evidence
Cannabis is not typically regarded as a psychedelic, but scientific evidence tells us it should be. Abundant anecdotal evidence of cannabis’ therapeutic applications, explored...
Backed by $15m in NIDA Funding, NYU and B.More Team Up to Trial Psilocybin...
Words by Josh Hardman, edited by Michael Haichin. Psychedelic researcher Michael Bogenschutz has scored a $15 million grant from the National Institute on Drug...
Compass Pathways Pushes Back Phase 3 Readouts, Lays Off 30% of Staff
This morning, Compass Pathways announced that it now expects to provide a top-line readout from its first phase 3 study (COMP005) of its psilocybin...
Philosophy and Psychedelics: Can Metaphysics Bring Meaning to Non-Ordinary States?
While the science of psychedelics is regularly discussed, the intersection of philosophy and psychedelics isn’t as much. Can an understanding of metaphysics bring more...
The Business of Psychedelics with Joe Moore and Jaime Fiorucci
Join us for an exclusive event exploring growing business opportunities in the emerging psychedelic industry. With the market projected to skyrocket in the coming...
Final Stretch for Question 4: Controversy, Advocacy, and Celebrity Voices Shape Psychedelic Vote
Coverage by Jack Gorsline for Psychedelic Alpha, edited by Josh Hardman. As election day draws nearer, psychedelic supporters and opponents around the world continue...
The Penn Psychedelics Collaborative and the Power of Interdisciplinary Connections
As the spectrum of interest in psychedelics broadens more every day, interdisciplinary connections become more important than ever. What is the Penn Psychedelics Collaborative?...
Pα+ Psychedelic Bulletin #178: VA Funding of Lykos Phase 3 ‘Definitely a Possibility’; Alto’s...
Late last Friday, Lykos Therapeutics announced that it has met with the FDA regarding the future of its MDMA for PTSD program, after the...
Natural Medicine Advisory Bulletin 14
Written by the Vicente LLP team as part of our Colorado Natural Medicine Health Act Tracker. Having completed the initial rulemaking push in July,...
Meet the Legal Team Fighting the DEA to Save Psychedelic Research
The U.S. Drug Enforcement Administration (DEA) is poised to ban two psychedelic compounds, DOI and DOC, which could deliver a disastrous blow to psychedelic...
What You Need to Know About Massachusetts’ Question 4 and the Natural Psychedelic Substances...
With the passing of the Natural Psychedelic Substances Act (Question 4), Massachusetts could be the next state to follow in Colorado and Oregon’s footsteps...
Psychedelics Take Centre Stage in Massachusetts’ Local Media
As some psychedelics advocates have vowed to redouble their state-by-state policy reform efforts in light of Lykos Therapeutics’ FDA rejection this summer, we’re renewing...
